TORRENT PHARMACEUTICALS
Back to All Ratios
|
TORRENT PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 79.96 | 72.82 | 57.67 | 42.52 | 56.42 |
What is the latest Cash Earnings per Share (CEPS) ratio of TORRENT PHARMACEUTICALS ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 79.96 |
| Mar2024 | 72.82 |
| Mar2023 | 57.67 |
| Mar2022 | 42.52 |
| Mar2021 | 56.42 |
How is Cash Earnings per Share (CEPS) of TORRENT PHARMACEUTICALS Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 79.96 | 9.80 | |
| Mar2024 | 72.82 | 26.27 | |
| Mar2023 | 57.67 | 35.63 | |
| Mar2022 | 42.52 | -24.64 | |
| Mar2021 | 56.42 | - | |
Other Financial Ratios of TORRENT PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹145,349.6 Cr | -1.5% | 3.3% | 37.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,735.0 Cr | -0.6% | 10.3% | 4.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹180,312.0 Cr | 1.4% | 11% | 11.5% | Stock Analytics | |
| CIPLA | ₹107,205.0 Cr | -2.6% | 7.9% | -13.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,592.0 Cr | -3.2% | 2.7% | 10.6% | Stock Analytics | |
| MANKIND PHARMA | ₹99,384.3 Cr | 1.4% | 15.8% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.5% |
3.3% |
37.6% |
| SENSEX | -4.3% |
-2.6% |
-7.6% |
You may also like the below Video Courses